|
369 First prescription signed by a hospital pharmacist A
hospital pharmacist has become the first pharmacist supplementary prescriber
known to The Pharmaceutical Journal ...more
369 SOS
fields seven candidates The Save Our Society campaign has confirmed that it is fielding candidates for each of the seven vacancies in this year’s election to the Royal Pharmaceutical Society’s Council
...more
369 Part-time
working and job-sharing on the increase among pharmacists in the NHS Part-time
working and job-sharing among pharmacists employed by the NHS in hospitals
and community health services is slowly rising ...more
369 Dual
language prescription forms introduced in Wales National Health
Service prescription forms printed in both English and Welsh have been
introduced in Wales ...more
370 Immediate
action urged as MRSA in children rises Researchers have called
for urgent action to tackle rising rates of infection with methicillin-resistant
Staphylococcus aureus in children ...more
370 Avoid
adding aminoglycoside to beta-lactam In the treatment of sepsis, adding an aminoglycoside to beta-lactams should be discouraged, say the authors of a systematic review and meta-analysis. “Fatality remains unchanged while the risk for adverse events is increased,” they comment
...more
370 Boots
withdraws indemnity cover for locums Boots no longer provides
professional indemnity cover for locums working in its stores. They now
have to use other indemnity arrangements to cover their activities ...more
370 Pharmacists
unhappy at work Pharmacists are among the least happy workers
in Britain, along with accountants, estate agents and media workers ...more
370 New
GP contract means new prescribing regulations New regulations
that restrict GP prescribing are to replace the regulations that created
the NHS blacklist and limited list. The drugs on the lists themselves
remain unchanged ...more
371 NICE
issues guidance on newer anti-epilepsy drugs Guidance on the
use of newer drugs for epilepsy in adults has been issued by the National
Institute for Clinical Excellence ...more
371 Acute
care services improve Services provided by acute care trusts
are improving, according to the Commission for Health Improvement ...more
371 Endorsement
for Avandamet Endorsement of the combination product Avandamet
(rosiglitazone/metformin) has been made for its use in type 2 diabetes
within NHS Scotland ...more
371 Heart
report published A Government report showing progress in the
treatment of coronary heart disease was published this week ...more
371 Better
care over winter Patients received a better service from the
NHS this winter than it has done previously, a new Government report
says ...more
372 Tailor
nicotine replacement therapy to the individual Tailoring nicotine
replacement therapy in certain smokers may increase their chances of
stopping, according to US researchers. Ethnicity, weight and level of
nicotine dependence could help health professionals decide whether to
use transdermal or nasal spray products, they state ...more
372 Nicotine
patch efficacy linked to genotype How effective nicotine patches
are may be related to genotype in women but not in men ...more
|
372 Smoking rates
fall in England Smoking prevalence in England dropped from
28 per cent in 1998 to 26 per cent in 2002 ...more
372 GSK wants
Zovirax to be general sale list medicine GlaxoSmithKline Consumer
Healthcare has asked to be allowed to sell Zovirax cold sore cream through
corner shops and convenience stores ...more
372 Smoking and
cognitive decline Smoking may accelerate cognitive decline
in the elderly by as much as five-fold, say researchers ...more
372 CHI risk
management tool Self-assessment tools to help NHS organisations
identify their strengths and weaknesses in relation to risk management
have been developed by the Commission for Health Improvement ...more
372 MeReC
Extra Hand hygiene, malaria prevention and prescribing
of newer antidepressants are the topics reviewed in the latest issue
of MeReC Extra ...more
373 Celesio watches
its profits rise Celesio, formerly known as GEHE, and the
German parent company of AAH Pharmaceuticals and LloydsPharmacy, has
reported an 8.8 per cent growth in pre-tax profit for its 2003 financial
year ...more
373 New NHS IT
leaders to aid implementation Deputy chief medical officer
Aidan Halligan and Department of Health director of delivery John Bacon
have joined the team leading the NHS information technology programme
in England to make sure it is implemented effectively ...more
373 PSNC produces
NHS guide A guide to the NHS in England and Wales has been
produced for community pharmacists by the Pharmaceutical Services Negotiating
Committee ...more
373 BNF and Pharmaid Pharmacists
are reminded not to throw away copies of BNF 46 now that the 47th edition
has been published ...more
373 Minimum wage
to rise National minimum wages will rise from 1 October ...more
374 New treatment
for lymphoma Patients with CD20-positive follicular B-cell
non-Hodgkin’s lymphoma, who are unresponsive to rituximab or who
have relapsed, may benefit from a new radioimmunotherapy product due
to be launched in April ...more
374 Nicotinamide
fails to impress in major diabetes trial For the second time
in two years, a major study designed to prevent the development of type
1 diabetes has ended in disappointment. A twice daily dose of the B vitamin,
nicotinamide, has failed to protect relatives of type 1 diabetes patients
from developing the disease ...more
374 NHS Direct
self-help guide now in Thomson directory NHS Direct has produced
a self-help guide to be delivered to people's homes in England as part
of the Thomson Local directory ...more
375 Pharmacists
Defence Association wins compensation and launches locum support The
recently formed Pharmacists’ Defence Association is showing early
results in improving the lot of pharmacy employees. Since its formation
in September 2003, the PDA has won £30,000 overall, in compensation
for pharmacists in claims against their employers ...more
375 Industry
loses £770m to PIs, but benefits offset some loss Parallel
imports cost the UK pharmaceutical industry more than £770m a year,
according to a study from the University of London’s Imperial College.
This is almost half the latest estimate of £1.4bn made by the Association
of the British Pharmaceutical Industry ...more
|
The
Pharmaceutical Journal